JPS5512422B1 - - Google Patents

Info

Publication number
JPS5512422B1
JPS5512422B1 JP7163471A JP7163471A JPS5512422B1 JP S5512422 B1 JPS5512422 B1 JP S5512422B1 JP 7163471 A JP7163471 A JP 7163471A JP 7163471 A JP7163471 A JP 7163471A JP S5512422 B1 JPS5512422 B1 JP S5512422B1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7163471A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS5512422B1 publication Critical patent/JPS5512422B1/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96Sulfur atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP7163471A 1970-09-14 1971-09-14 Pending JPS5512422B1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7215670A 1970-09-14 1970-09-14

Publications (1)

Publication Number Publication Date
JPS5512422B1 true JPS5512422B1 (es) 1980-04-02

Family

ID=22105942

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7163471A Pending JPS5512422B1 (es) 1970-09-14 1971-09-14

Country Status (14)

Country Link
JP (1) JPS5512422B1 (es)
AT (1) AT323187B (es)
AU (1) AU468590B2 (es)
BE (1) BE772381A (es)
CA (1) CA983489A (es)
CH (2) CH552575A (es)
ES (2) ES394830A1 (es)
FR (1) FR2106514B1 (es)
GB (1) GB1353357A (es)
KE (1) KE2573A (es)
MY (1) MY7500253A (es)
NL (1) NL173400C (es)
SE (1) SE401673B (es)
ZA (1) ZA715851B (es)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983000044A1 (en) * 1981-06-22 1983-01-06 Mochida Pharm Co Ltd Novel aminosulfonylbenzoic acid derivatives and process for their preparation
JPS6323210U (es) * 1986-07-31 1988-02-16
JPH0248510U (es) * 1988-09-28 1990-04-04
JP2003508380A (ja) * 1999-09-01 2003-03-04 アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング スルホニルカルボキサミド誘導体、その調製方法および医薬としてのその使用
JP2003508381A (ja) * 1999-09-01 2003-03-04 アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 高脂血症の予防または治療用薬剤の製造のためのビススルホンアミドの使用

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929803A (en) * 1974-05-28 1975-12-30 Pfizer Aryl carboxylic acids
EP0068408A1 (en) * 1980-11-10 1983-01-05 Mochida Pharmaceutical Co., Ltd. Antiviral compositions and a method for treating virus diseases
JPS58192863A (ja) * 1982-05-06 1983-11-10 Hodogaya Chem Co Ltd 新規アミノスルホニル安息香酸エステル誘導体
SE8203878L (sv) * 1981-06-22 1982-12-23 Mochida Pharm Co Ltd Antiviruskomposition
DE3732374A1 (de) * 1987-09-25 1989-04-06 Basf Lacke & Farben Zink-, blei- und/oder calciumsalze von carbonsaeuren und deren verwendung als korrosionsschutzmittel

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1525352A (fr) * 1967-04-06 1968-05-17 Ile De France Procédé de préparation des acides 2-alcoxy-5-sulfamido-benzoïques
US3444177A (en) * 1962-03-09 1969-05-13 Ciba Geigy Corp N-phenyl - 5 - (dimethylsulfamoyl)-anthranilic acid,esters and amides thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3444177A (en) * 1962-03-09 1969-05-13 Ciba Geigy Corp N-phenyl - 5 - (dimethylsulfamoyl)-anthranilic acid,esters and amides thereof
FR1525352A (fr) * 1967-04-06 1968-05-17 Ile De France Procédé de préparation des acides 2-alcoxy-5-sulfamido-benzoïques

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983000044A1 (en) * 1981-06-22 1983-01-06 Mochida Pharm Co Ltd Novel aminosulfonylbenzoic acid derivatives and process for their preparation
JPS6323210U (es) * 1986-07-31 1988-02-16
JPH0248510U (es) * 1988-09-28 1990-04-04
JP2003508380A (ja) * 1999-09-01 2003-03-04 アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング スルホニルカルボキサミド誘導体、その調製方法および医薬としてのその使用
JP2003508381A (ja) * 1999-09-01 2003-03-04 アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 高脂血症の予防または治療用薬剤の製造のためのビススルホンアミドの使用
JP4792186B2 (ja) * 1999-09-01 2011-10-12 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング スルホニルカルボキサミド誘導体、その調製方法および医薬としてのその使用
JP4982021B2 (ja) * 1999-09-01 2012-07-25 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 高脂血症の予防または治療用薬剤の製造のためのビススルホンアミドの使用

Also Published As

Publication number Publication date
ZA715851B (en) 1972-05-31
ES394830A1 (es) 1974-12-01
AT323187B (de) 1975-06-25
KE2573A (en) 1975-10-31
AU468590B2 (en) 1976-01-15
MY7500253A (en) 1975-12-31
SE401673B (sv) 1978-05-22
GB1353357A (en) 1974-05-15
NL173400B (nl) 1983-08-16
FR2106514A1 (es) 1972-05-05
BE772381A (fr) 1972-03-09
NL7112598A (es) 1972-03-16
DE2145686B2 (de) 1977-07-07
NL173400C (nl) 1984-01-16
CA983489A (en) 1976-02-10
AU3308471A (en) 1973-03-08
CH569706A5 (es) 1975-11-28
DE2145686A1 (de) 1972-04-20
CH552575A (fr) 1974-08-15
ES421977A1 (es) 1976-05-01
FR2106514B1 (es) 1975-08-01

Similar Documents

Publication Publication Date Title
AR204384A1 (es)
ATA96471A (es)
AU2044470A (es)
AU1146470A (es)
AU1473870A (es)
AU2130570A (es)
AU1336970A (es)
AU1326870A (es)
AU2017870A (es)
AU1716970A (es)
AU2085370A (es)
AU1517670A (es)
AU1833270A (es)
AU1591370A (es)
AU1872870A (es)
AU2144270A (es)
AU1328670A (es)
AU1277070A (es)
AU1343870A (es)
AU1247570A (es)
AU2131570A (es)
AU2130770A (es)
AU1235770A (es)
AU1581370A (es)
AU1189670A (es)